CY1298A - Pharmaceutical compositions containing ergot alkaloids and heparin - Google Patents

Pharmaceutical compositions containing ergot alkaloids and heparin Download PDF

Info

Publication number
CY1298A
CY1298A CY1298A CY129879A CY1298A CY 1298 A CY1298 A CY 1298A CY 1298 A CY1298 A CY 1298A CY 129879 A CY129879 A CY 129879A CY 1298 A CY1298 A CY 1298A
Authority
CY
Cyprus
Prior art keywords
heparin
formula
compound
pharmaceutical compositions
compositions containing
Prior art date
Application number
CY1298A
Other languages
English (en)
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of CY1298A publication Critical patent/CY1298A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
CY1298A 1978-03-06 1979-03-02 Pharmaceutical compositions containing ergot alkaloids and heparin CY1298A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782809618 DE2809618A1 (de) 1978-03-06 1978-03-06 Neues therapeutisches praeparat und verfahren zu dessen herstellung

Publications (1)

Publication Number Publication Date
CY1298A true CY1298A (en) 1985-10-18

Family

ID=6033695

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1298A CY1298A (en) 1978-03-06 1979-03-02 Pharmaceutical compositions containing ergot alkaloids and heparin

Country Status (15)

Country Link
JP (1) JPS54126736A (fr)
BE (1) BE874626R (fr)
CH (1) CH639271A5 (fr)
CY (1) CY1298A (fr)
DE (1) DE2809618A1 (fr)
FR (1) FR2419070A2 (fr)
GB (1) GB2015338B (fr)
HK (1) HK81085A (fr)
IE (1) IE48192B1 (fr)
KE (1) KE3548A (fr)
NL (1) NL7901702A (fr)
NZ (1) NZ189817A (fr)
PH (1) PH16800A (fr)
SG (1) SG49185G (fr)
ZA (1) ZA791032B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2945636A1 (de) * 1979-11-12 1981-05-21 Sandoz-Patent-GmbH, 7850 Lörrach Stabile loesungen von hydrierten ergotalkaloiden bzw. ihren salzen und heparin bzw. seinen salzen sowie verfahren zu deren herstellung
CH656533A5 (de) * 1982-12-10 1986-07-15 Sandoz Ag Therapeutisches praeparat enthaltend hydrierte ergotalkaloide und niedermolekulares heparin.
DE3343818A1 (de) * 1982-12-10 1984-06-14 Sandoz-Patent-GmbH, 7850 Lörrach Neues therapeutisches praeparat enthaltend hydrierte ergotalkaloide und heparin
RU2107492C1 (ru) * 1997-01-22 1998-03-27 Открытое акционерное общество "Нижегородский химико-фармацевтический завод" Мазь для лечения тромбофлебита

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE441142B (sv) * 1975-12-04 1985-09-16 Sandoz Ag Forfarande for framstellning av ett terapeutiskt preparat med antitrombotiska egenskaper

Also Published As

Publication number Publication date
IE48192B1 (en) 1984-10-31
FR2419070A2 (fr) 1979-10-05
JPS54126736A (en) 1979-10-02
KE3548A (en) 1985-08-02
NZ189817A (en) 1981-04-24
FR2419070B1 (fr) 1982-08-06
DE2809618A1 (de) 1979-09-20
SG49185G (en) 1986-01-17
CH639271A5 (de) 1983-11-15
GB2015338B (en) 1982-08-18
HK81085A (en) 1985-10-25
GB2015338A (en) 1979-09-12
BE874626R (fr) 1979-09-05
NL7901702A (nl) 1979-09-10
PH16800A (en) 1984-03-01
ZA791032B (en) 1980-10-29
IE790701L (en) 1979-09-06

Similar Documents

Publication Publication Date Title
ZA918734B (en) Cyclic imino derivatives, pharmaceutical compositions containing these compounds and processes for preparing them.
US3851056A (en) Method of depressing fatty acids and triglycerides
IE861984L (en) Crystalline salt of guanine derivative
JPH05246856A (ja) 改良イフォスファミド凍結乾燥組成物
EP0189941B1 (fr) Compositions antibiotiques
MY100095A (en) 2-oxo-imidazolidine compounds, a process for preparing the same and a pharmaceutical composition.
AU5791190A (en) New peptide derivatives, process for preparing them and pharmaceutical compositions containing them
US4663348A (en) Furosemide salts and pharmaceutical preparations thereof
CY1298A (en) Pharmaceutical compositions containing ergot alkaloids and heparin
IL93259A0 (en) Aryl derivatives,their preparation and pharmaceutical compositions containing them
KR900014396A (ko) 티에노-트리아졸로-디아제핀 유도체, 그의 제조 방법 및 그를 함유하는 치료 조성물
US4083981A (en) Analgetic composition
WO1992022527A3 (fr) Derives de pyrrolidine 3-substitues comme antagonistes du calcium
EP0302263B1 (fr) Composition thérapeutique pour combattre le SIDA
CS214798B2 (en) Method of stabilization of active substances
GB2062640A (en) Fosfomycin salt
IL70691A0 (en) 5-(4-vinyl-or 4-ethynylbenzoyl)-1,2-dihydro-3h-pyrrolo(1,2-a)pyrrole-1-carboxylic acids and derivatives thereof,their preparation and pharmaceutical compositions containing them
US4451458A (en) Method for the treatment of post-operative thrombosis
US4125610A (en) Antibacterial compositions
US4033816A (en) Process for inhibiting platelet aggregation
CA1079194A (fr) Compose pharmaceutique pour le traitement prophylactique des thromboses
US3821409A (en) Method of treatment
IE44359B1 (en) Pharmaceutical compositions containing an ergot alkaloid and heparin
US3749781A (en) Pharmaceutical composition and method of treatment
US4110161A (en) Process for inhibiting platelet aggregation